SCHEMBL8226952

SCHEMBL8226952

Nc1cccc(-c2cc([C@H]3CCCN3)no2)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 2/20 0.39
MAP4K4 O95819 2/20 0.38
TSHR P16473 1/20 0.36
RECQL P46063 1/20 0.36
CHRM5 P08912 3/20 0.35
CHRM3 P20309 3/20 0.35
CHRM1 P11229 2/20 0.35
CHRM2 P08172 2/20 0.35
CHRM4 P08173 2/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNA4 P43681 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
METAP2 P50579 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14387422 1.00 NR1H4 (0.39) NR1H4MAP4K4TSHRRECQLCHRM5
SCHEMBL8226012 0.96 NR1H4 (0.40) NR1H4MAP4K4TSHRRECQLCHRNB2
SCHEMBL8226114 0.96 NR1H4 (0.40) NR1H4MAP4K4TSHRRECQLCHRNB2
SCHEMBL16464581 0.85 RAB9A (0.47) NR1H4
SCHEMBL4082606 0.85 RAB9A (0.47) NR1H4
SCHEMBL3975733 0.85 RAB9A (0.47) NR1H4
SCHEMBL5483346 0.85 RAB9A (0.48) NR1H4
SCHEMBL2898408 0.85 CASP3 (0.41) NR1H4CHRM5CHRM3CHRM1CHRM2
SCHEMBL2899343 0.85 RPS6KB1 (0.42) NR1H4
SCHEMBL2898404 0.85 CASP3 (0.41) NR1H4CHRM5CHRM3CHRM1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007130820-A2 MGLUR5 MODULATORS I ASTRAZENECA AB (SE) 2007-11-15 WO disclosed
WO-2007130823-A2 POLYCYCLIC HETEROCYCLIC COMPOUNDS AND THEIR USE AS MODULATORS OF THE METABOTROPIC GLUTAMATE 5 RECEPTOR ASTRAZENECA AB (SE) 2007-11-15 WO disclosed